Thermal ablation of prostate diseases: advantages and limitations

References

• Berry Si, Coffey DS, Walsh PC, Ewing LL. The development of human benign prostatic hyperplasia with age. J Urol 1984; 132: 474–9.
   PubMed Web of Science ®Google Scholar
• Jemal A, Murray T, Samuels A, Ghafoor A, Ward E, Thun Mi. Cancer statistics, 2003. CA Cancer J Clin 2003; 53: 5–26.
   PubMed Web of Science ®Google Scholar
• Onik GM, Cohen JK, Reyes GD, Rubinsky B, Chang Z, Baust J. Transrectal ultrasound-guided percutaneous radical cryosurgical ablation of the prostate. Cancer 1993; 72: 1291–9.
   PubMed Web of Science ®Google Scholar
• Gonder MJ, Soanes WA, Shulman S. Cryosurgical treatment of the prostate. Invest Urol 1966; 3: 372–8.
   PubMedGoogle Scholar
• Flocks RH, Nelson CM, Boatman DL. Perineal cryosurgery for prostatic carcinoma. J Urol 1972; 108: 933–5.
   Google Scholar
• Foster RS, Bihrle R, Sanghvi NT, Fry FJ, Donohue JP. High-intensity focused ultrasound in the treatment of prostatic disease. Eur Urol 1993; 23 (Suppl 1): 29–33.
   Google Scholar
• Madersbacher S, Kratzik C, Szabo N, Susani M, Vingers L, Marberger M. Tissue abla-tion in benign prostatic hyperplasia with high-intensity focused ultrasound. Eur Urol 1993; 23 (Suppl 1): 39–43.
   PubMedGoogle Scholar
• Watkin NA, Ter Haar GR, Morris SB, Woodhouse CR. The urological applications of focused ultrasound surgery. Br J Urol 1995; 75 (Suppl 1): 1–8.
   PubMedGoogle Scholar
• Harada T, Etori K, Kumazaki T, Nishizawa O, Noto H, Tsuchida S. Microwave surgical treatment of diseases of prostate. Urology 1985; 26: 572–6.
   PubMed Web of Science ®Google Scholar
• Astrahan MA, Sapozink MD, Cohen D, Luxton G, Kampp TD, Boyd S, Petrovich Z. Microwave applicator for transurethral hyperthermia of benign prostatic hyperplasia. Int J Hypertherrnia 1989; 5: 283–96.
   PubMed Web of Science ®Google Scholar
• Schulman CC, Zlotta AR, Rasor JS, Hourriez L, Noel JC, Edwards SD. Transurethral needle ablation (TUNA): safety, feasibility, and tolerance of a new office procedure for treatment of benign prostatic hyperplasia. Eur Urol 1993; 24: 415–23.
   PubMed Web of Science ®Google Scholar
• Ramon J, Goldwasser B, Shenfeld O, Engelberg S, Rasor JS, Edwards SD. Needle ablation using radio frequency current as a treatment for benign prostatic hyperplasia: experimental results in ex vivo human prostate. Eur Urol 1993; 24: 406–10.
   PubMed Web of Science ®Google Scholar
• Roth RA, Aretz HT. Transurethral ultrasound-guided laser-induced prostatectomy (TULIP procedure): a canine prostate feasibility study. J Urol 1991; 146: 1128–35.
   PubMed Web of Science ®Google Scholar
• Johnson DE, Price RE, Cromeens DM. Pathologic changes occurring in the prostate following transurethral laser prostatectomy. Lasers Surg Med 1992; 12: 254–63.
   PubMedGoogle Scholar
• Kabalin JN. Laser prostatectomy performed with a right angle firing neodymium:YAG laser fiber at 40 watts power setting. J Urol 1993; 150: 95–9.
   PubMed Web of Science ®Google Scholar
• McNicholas TA, Steger AC, Bown SG. Interstitial laser coagulation of the prostate. An experimental study. Br J Urol 1993; 71: 439–44.
   Google Scholar
• Tucker RD, Huidobro C, Larson T, Platz CE. Use of permanent interstitial temperature self-regulating rods for ablation of prostate cancer. J Endourol 2000; 14: 511–7.
   PubMed Web of Science ®Google Scholar
• Streffer C. Biological basis of thermotherapy. In: Gautherie M, ed. Biological basis of oncologic therrnotherapy. Berlin: Springer-Verlag, 1990; 39–43.
   Google Scholar
• Dewhirst MW, Winget JM, Edelstein-Keshet L, Sylvester J, Engler M, Thrall DE, et al. Clinical application of thermal isoeffect dose. Int J Hypertherrnia 1987; 3: 307–18.
   PubMed Web of Science ®Google Scholar
• Roehrborn CG. Minimally invasive therapies for benign prostatic hyperplasia. In: McConnell JDaS, PT, ed. Atlas of Clinical Urology. Philadelphia: Current Medicine, Inc, 1999; 4.1-4.24.
   Google Scholar
• Mazur P. Cryobiology: the freezing of biological systems. Science 1970; 168: 939–49.
   PubMed Web of Science ®Google Scholar
• Zippe CD. Cryosurgical ablation for prostate cancer: a current review. Sernin Urol 1995; 13: 148–56.
   Google Scholar
• Tatsutani K, Rubinsky B, Onik G, Dahiya R. Effect of thermal variables on frozen human primary prostatic adenocarcinoma cells. Urology 1996; 48: 441–7.
   PubMed Web of Science ®Google Scholar
• Larson TR, Rrobertson DW, Corica A, Bostwick DG. In vivo interstitial temperature mapping of the human prostate during cryosurgery with correlation to histopathologic outcomes. Urology 2000; 55: 547–52.
   PubMed Web of Science ®Google Scholar
• Weber SM, Lee FT, Jr, Chinn DO, Warner T, Chosy SG, Mahvi DM. Perivascular and intralesional tissue necrosis after hepatic cryoablation: results in a porcine model. Surgery 1997; 122: 742–7.
   Google Scholar
• Montorsi F, Guazzoni G, Rigatti P, Pizzini G, Miani A. Is there a role for transrectal microwave hyperthermia in the treatment of benign prostatic hyperplasia? A critical review of a six-year experience. J Endourol 1995; 9: 333–7.
   Google Scholar
• McCullough DL, Roth RA, Babayan RK, Gordon JO, Reese JH, Crawford ED, Fuselier HA, Smith JA, Murchison RJ, Kaye KW. Transurethral ultrasound-guided laser-induced prostatectomy: National Human Cooperative Study results. J Urol 1993; 150: 1607–11.
   PubMed Web of Science ®Google Scholar
• Kabalin JN, Bite G, Doll S. Neodymium:YAG laser coagulation prostatectomy: 3 years of experience with 227 patients. J Urol 1996; 155: 181–5.
   Google Scholar
• Costello A.1, Lusaya DG, Crowe HR. Transurethral laser ablation of the prostate-long-term results. World J Urol 1995; 13: 119–22.
   Google Scholar
• Marks LS, Treiger B, Dorey FJ, Shery ED. Prostatic aperture resulting from visual laser ablation: classification system based on follow-up endoscopy. J Endourol 1995; 9: 175–81.
   PubMed Web of Science ®Google Scholar
• Muschter R, Hofstetter A. Technique and results of interstitial laser coagulation. World J Urol 1995; 13: 109–14.
   PubMed Web of Science ®Google Scholar
• Kursh ED, Concepcion R, Chan S, Hudson P, Ratner M, Eyre R. Interstitial laser coagulation versus transurethral prostate resection for treating benign prostatic obstruc-tion: a randomized trial with 2-year follow-up. Urology 2003; 61: 573–8.
   PubMed Web of Science ®Google Scholar
• Liedberg F, Adell L, Hagberg G, Palmqvist IB. Interstitial laser coagulation versus transurethral resection of the prostate for benign prostatic enlargementa prospectiverandomized study. Scand J Urol Nephrol 2003; 37: 494–7.
   PubMed Web of Science ®Google Scholar
• Blute ML, Tomera KM, Hellerstein DK, McKiel CF, Jr., Lynch JR, Regan JB, Sankey NE. Transurethral microwave thermotherapy for management of benign prostatic hyper-plasia: results of the United States Prostatron Cooperative Study. J Urol 1993; 150: 1591–6.
   Google Scholar
• Larson TR, Blute ML, Bruskewitz RC, Mayer RD, Ugarte RR, Utz WJ. A high-efficiency microwave thermoablation system for the treatment of benign prostatic hyperplasia: results of a randomized, sham-controlled, prospective, double-blind, multi-center clinical trial. Urology 1998; 51: 731–42.
   PubMed Web of Science ®Google Scholar
• De La Rosette .1.1, Floratos DL, Severens JL, Kiemeney LA, Debruyne FM, Pilar Laguna M. Transurethral resection vs microwave thermotherapy of the prostate: a cost-consequences analysis. BJU Int 2003; 92: 713–8.
   Google Scholar
• Tsai YS, Lin JS, Tong YC, Tzai TS, Yang WH, Chang CC, Cheng HL, Lin YM, Jou YC. Transurethral microwave thermotherapy for symptomatic benign prostatic hyperplasia: long-term durability with Prostcare. Eur Urol 2001; 39: 688–92; discussion 693-4.
   Google Scholar
• Floratos DL, Kiemeney LA, Rossi C, Kortmann BB, Debruyne FM, de La Rosette M. Long-term followup of randomized transurethral microwave thermotherapy versus transurethral prostatic resection study. J Urol 2001; 165: 1533–8.
   Google Scholar
• Thalmann GN, Mattei A, Treuthardt C, Burkhard FC, Studer UE. Transurethral microwave therapy in 200 patients with a minimum followup of 2 years: urodynamic and clinical results. J Urol 2002; 167: 2496–501.
   Google Scholar
• Stravodimos KG, Anderson AE, Goldfischer ER, Jabbour ME, Klima WJ, Smith AD. Necrosis of the urethra and tissue sloughing: a delayed complication after transurethral microwave thermotherapy. J Endourol 1998; 12: 379–80.
   PubMed Web of Science ®Google Scholar
• Zlotta AR, Giannakopoulos X, Maehlum O, Ostrem T, Schulman CC. Long-term evaluation of transurethral needle ablation of the prostate (TUNA) for treatment of symptomatic benign prostatic hyperplasia: clinical outcome up to five years from three centers. Eur Urol 2003; 44: 89–93.
   Google Scholar
• Hill B, Belville W, Bruskewitz R, Issa M, Perez-Marrero R, Roehrborn C, Terris M, Naslund M. Transurethral needle ablation versus transurethral resection of the prostate for the treatment of symptomatic benign prostatic hyperplasia: 5-year results of a prospective, randomized, multicenter clinical trial. J Urol 2004; 171: 2336–40.
   Google Scholar
• Breda G, Isgro A. Treatment of benign prostatic hyperplasia with water-induced thermotherapy: experience of a single institution. J Endourol 2002; 16: 123–6.
   PubMed Web of Science ®Google Scholar
• Roehrborn CG, Burkhard FC, Bruskewitz RC, Issa MM, Perez-Marrero R, Naslund MJ, et al. The effects of transurethral needle ablation and resection of the prostate on pressure flow urodynamic parameters: analysis of the United States randomized study. J Urol 1999; 162: 92–7.
   Google Scholar
• Zlotta AR, Raviv G, Peny MO, Noel JC, Haot J, Schulman CC. Possible mechanisms of action of transurethral needle ablation of the prostate on benign prostatic hyperplasia symptoms: a neurohistochemical study. J Urol 1997; 157: 894–9.
   PubMed Web of Science ®Google Scholar
• Perachino M, Bozzo W, Puppo P, Vitali A, Ardoino S, Ferro MA. Does transurethral thermotherapy induce a long-term alpha blockade? An immunohistochemical study. Eur Urol 1993; 23: 299–301.
   PubMed Web of Science ®Google Scholar
• Lee F, Bahn DK, Badalament RA, Kumar AB, Klionsky D, Onik GM, Chinn DO, Greene C. Cryosurgery for prostate cancer: improved glandular ablation by use of 6 to 8 cryoprobes. Urology 1999; 54: 135–40.
   PubMed Web of Science ®Google Scholar
• Connolly JA, Shinohara K, Presti JC, Jr., Carroll PR. Prostate-specific antigen after cryosurgical ablation of the prostate. Defining the appropriate response. Urol Clin North Am 1997; 24: 415–20.
   Google Scholar
• Shinohara K, Connolly JA, Presti JC, Jr., Carroll PR. Cryosurgical treatment of localized prostate cancer (stages Ti to T4): preliminary results. J Urol 1996; 156: 115–20; discussion 120-1.
   Google Scholar
• Pisters LL, von Eschenbach AC, Scott SM, Swanson DA, Dinney CP, Pettaway CA, et al. The efficacy and complications of salvage cryotherapy of the prostate. J Urol 1997; 157: 921–5.
   PubMed Web of Science ®Google Scholar
• Shinohara K, Rhee B, Presti JC, Jr., Carroll PR. Cryosurgical ablation of prostate cancer: patterns of cancer recurrence. J Urol 1997; 158: 2206–9; discussion 2209-10.
   Google Scholar
• Bahn DK, Lee F, Solomon MH, Gontina H, Klionsky DL, Lee FT, Jr. Prostate cancer: US-guided percutaneous cryoablation. Work in progress. Radiology 1995; 194: 551–6.
   Google Scholar
• Greene GF, Pisters LL, Scott SM, Von Eschenbach AC. Predictive value of prostate specific antigen nadir after salvage cryotherapy. J Urol 1998; 160: 86–90.
   Google Scholar
• Long JP, Fallick ML, LaRock DR, Rand W. Preliminary outcomes following cryosurgical ablation of the prostate in patients with clinically localized prostate carci-noma. J Urol 1998; 159: 477–84.
   PubMed Web of Science ®Google Scholar
• Trachtenberg J, Chen J, Kucharczyk W, Toi A, Lancaster C. Microwave thermoablation for localized prostate cancer after failed radiation therapy: role of neoadjuvant hormonal therapy. Mol Urol 1999; 3: 247–50.
   Google Scholar
• Sherar MD, Gertner MR, Yue CK, O'Malley ME, Toi A, Gladman AS, Davidson SR, Trachtenberg J. Interstitial microwave thermal therapy for prostate cancer: method of treatment and results of a phase I/II trial. J Urol 2001; 166: 1707–14.
   Google Scholar
• Siperstein A, Garland A, Engle K, Rogers S, Berber E, String A, Foroutani A, Ryan T. Laparoscopic radiofrequency ablation of primary and metastatic liver tumors. Technical considerations. Surg Endosc 2000; 14: 400–5.
   PubMed Web of Science ®Google Scholar
• Lewin JS, Connell CF, Duerk JL, Chung YC, Clampitt ME, Spisak J, Gazelle GS, Haaga JR. Interactive MRI-guided radiofrequency interstitial thermal ablation of abdominal tumors: clinical trial for evaluation of safety and feasibility. J Magn Reson Imaging 1998; 8: 40–7.
   PubMed Web of Science ®Google Scholar
• Wood BJ, Bates S. Radiofrequency thermal ablation of a splenic metastasis. J Vase Interv Radiol 2001; 12: 261–3.
   PubMed Web of Science ®Google Scholar
• Zlotta AR, Djavan B, Matos C, Noel JC, Peny MO, Silverman DE, Marberger M, Schulman CC. Percutaneous transperineal radiofrequency ablation of prostate tumour: safety, feasibility and pathological effects on human prostate cancer. Br J Urol 1998; 81: 265–75.
   PubMedGoogle Scholar
• Djavan B, Susani M, Shariat S, Zlotta AR, Silverman DE, Schulman CC, Marberger M. Transperineal radiofrequency interstitial tumor ablation (RITA) of the prostate. Tech Urol 1998; 4: 103–9.
   Google Scholar
• Shariat SBF, Slawin K. Initial experience with radiofrequency interstitial tumor ablation (RITA) for the treatment of prostate cancer. J Urol 2001; 165 (suppl): 288.
   Google Scholar
• Lilly MB, Brezovich IA, Atkinson WJ. Hyperthermia induction with thermally self-regulated ferromagnetic implants. Radiology 1985; 154: 243–4.
   Google Scholar
• Friedrichs R, Loehing SA, Rudolf B. Local recurrence of prostate cancer: treatment by thermal ablation using interstitial temperature self-regulating seeds. European Urology, 33 (S1)54,1998 (abstract).
   Google Scholar
• Deger S, Bohmer D, Turk I, Franke M, Roigas J, Budach V, Loening SA. Thermoradiotherapy with interstitial thermoseeds in treatment of local prostatic carci-noma. Initial results of a phase II study. Urologe A 2001; 40: 195–8.
   Google Scholar
• Sanghvi NT, Foster RS, Bihrle R, Casey R, Uchida T, Phillips MH, Syrus J, Zaitsev AV, Marich KW, Fry FJ. Noninvasive surgery of prostate tissue by high intensity focused ultrasound: an updated report. Eur J Ultrasound 1999; 9: 19–29.
   PubMedGoogle Scholar
• Gelet A, Chapelon JY, Bouvier R, Souchon R, Pangaud C, Abdelrahim AF, Cathignol D, Dubernard JM. Treatment of prostate cancer with transrectal focused ultrasound: early clinical experience. Eur Urol 1996; 29: 174–83.
   PubMed Web of Science ®Google Scholar
• Beerlage HP, van Leenders GJ, Oosterhof GO, Witjes JA, Ruijter ET, van de Kaa CA, Debruyne FM, de la Rosette M. High-intensity focused ultrasound (HIFU) followed after one to two weeks by radical retropubic prostatectomy: results of a prospective study. Prostate 1999; 39: 41–6.
   PubMed Web of Science ®Google Scholar
• Chaussy C, Thuroff S. Results and side effects of high-intensity focused ultrasound in localized prostate cancer. J Endourol 2001; 15: 437–40; discussion 447-8.
   PubMed Web of Science ®Google Scholar
• Gelet A, Chapelon JY, Bouvier R, Rouviere O, Lyonnet D, Dubernard JM. Transrectal high intensity focused ultrasound for the treatment of localized prostate cancer: factors influencing the outcome. Eur Urol 2001; 40: 124–9.
   PubMed Web of Science ®Google Scholar
• Miles BJ. High-intensity focused ultrasonography (HIFU) in the treatment of radiorecur-rent prostate cancer. Personal communication, 2001.
   Google Scholar
• Vallancien G, Prapotnich D, Cathelineau X, Baumert H, Rozet F. Transrectal focused ultrasound combined with transurethral resection of the prostate for the treatment of localized prostate cancer: feasibility study. J Urol 2004; 171: 2265–7.
   Google Scholar
• Rouviere O, Lyonnet D, Raudrant A, Colin-Pangaud C, Chapelon JY, Bouvier R, Dubernard JM, Gelet A. MRI appearance of prostate following transrectal HIFU abla-tion of localized cancer. Eur Urol 2001; 40: 265–74.
   Google Scholar
• Rubinsky B, Gilbert JC, Onik GM, Roos MS, Wong ST, Brennan KM. Monitoring cryosurgery in the brain and in the prostate with proton NMR. Cryobiology 1993; 30: 191–9.
   PubMed Web of Science ®Google Scholar
• Morikawa S, Inubushi T, Kurumi Y, Naka S, Sato K, Demura K, Tani T, Hague HA, Tokuda J, Hata N. Advanced computer assistance for magnetic resonance-guided micro-wave thermocoagulation of liver tumors. Acad Radiol 2003; 10: 1442–9.
   PubMed Web of Science ®Google Scholar
• Lazebnik RS, Weinberg BD, Breen MS, Lewin JS, Wilson DL. Three-dimensional model of lesion geometry for evaluation of MR-guided thermal ablation therapy. Acad Radiol 2002; 9: 1128–38.
   Google Scholar
• Gilbert JC, Rubinsky B, Wong ST, Brennan KM, Pease GR, Leung PP. Temperature determination in the frozen region during cryosurgery of rabbit liver using MR image analysis. Magn Reson Imaging 1997; 15: 657–67.
   PubMed Web of Science ®Google Scholar
• Cowles RS, 3rd, Kabalin JN, Childs S, Lepor H, Dixon C, Stein B, Zabbo A. A prospective randomized comparison of transurethral resection to visual laser ablation of the prostate for the treatment of benign prostatic hyperplasia. Urology 1995; 46: 155–60.
   PubMed Web of Science ®Google Scholar
• Miller PD, Kastner C, Ramsey EW, Parsons K. Cooled thermotherapy for the treatment of benign prostatic hyperplasia: durability of results obtained with the Targis System. Urology 2003; 61: 1160–4; discussion 1164-5.
   PubMed Web of Science ®Google Scholar
• Cimentepe E, Unsal A, Saglam R. Randomized clinical trial comparing transurethral needle ablation with transurethral resection of the prostate for the treatment of benign prostatic hyperplasia: results at 18 months. J Endourol 2003; 17: 103–7.
   Google Scholar
• Muschter R. Conductive heat: hot water-induced thermotherapy for ablation of prostatic tissue. J Endourol 2003; 17: 609–16.
   PubMed Web of Science ®Google Scholar
• Cioanta I, Muschter R. Water-induced thermotherapy for benign prostatic hyperplasia. Tech Urol 2000; 6: 294–9.
   PubMedGoogle Scholar